Ed Freedman is an Operating Partner at Engine Ventures and serves as a Board Member for Biobot Analytics, Kytopen, and Lucy Therapeutics.
Ed has over 20 years of leadership experience directing finance, legal and operational activities in companies across multiple industries including biotechnology, clean technology and venture capital. He combines an entrepreneurial approach to company-building with the strong analytical and organizational skills needed to address the complex challenges of highly-innovative businesses. Ed earned his JD from Boston College Law School and his BSBA in Accounting from Boston University.